Table 7 Surgeons’ knowledge and opinion towards the assessment of resectability of PC
Agree (%) | Disagree (%) | Unsure (%) | Missing (%) | |
|---|---|---|---|---|
the resectability can be assessed by: | ||||
CA19–9 | 392(55.6) | 254(36.0) | 6(0.9) | 53(7.5) |
CT | 632(89.7) | 56(7.9) | 1(0.1) | 16(2.3) |
MRI | 597(84.7) | 77(10.9) | 1(0.1) | 30(4.3) |
PET | 445(63.1) | 173(24.5) | 9(1.3) | 78(11.1) |
ERCP | 419(59.4) | 208(29.5) | 3(0.4) | 75(10.6) |
Selective angiography | 506(71.8) | 122(17.3) | 4(0.6) | 73(10.4) |
CT Loyer stagesa | ||||
Type A: resectable | 572 (81.1) | 80(11.4) | 18(2.6) | 35(5.0) |
Type B: resectable | 534(75.7) | 122(17.3) | 5(0.7) | 44(6.2) |
Type C: resectable in half of patients | 483(68.5) | 146(20.7) | 4(0.6) | 72(10.2) |
Type D: resectable in half of patients | 438(62.1) | 168(23.8) | 8(1.1) | 91(12.9) |
Type E: non-resectable | 411(58.3) | 183(26.0) | 4(0.6) | 107(15.2) |
Type F: non-resectable | 540(76.6) | 107(15.2) | 8(1.1) | 50(7.1) |